FundamentalVR Revolutionizes Surgical Training with Advanced AI Capabilities

FundamentalVR, global leader in immersive surgical training, announces groundbreaking advancements in its Fundamental Surgery platform, integrating cutting-edge artificial intelligence (AI) capabilities to drive predictive insights, enhance surgical proficiency, and accelerate skills acquisition. The company leverages this data to drive valuable insights for customers, fostering advancements in surgical training and beyond.

Harnessing the power of AI, FundamentalVR’s real-time data assessments can now predict surgical behavior and performance with unprecedented accuracy. By leveraging AI algorithms, the platform is able to track and analyze user gestures through telemetry data, in some cases achieving an impressive predictive accuracy rate of 98.5%. This predictive modeling empowers medical device companies and educators with analytics and data science techniques for more informed decisions around product design, training efficacy, and user skill levels, ultimately enhancing surgical techniques and improving patient outcomes.

“Our AI-driven approach marks a transformative shift in surgical training,” said Richard Vincent, Co-Founder and CEO at FundamentalVR. “By providing real-time insights and personalized guidance, Fundamental Surgery is revolutionizing how surgeons acquire and refine their skills, ultimately leading to safer and more effective patient care.”

The platform’s AI capabilities extend beyond performance prediction to offer the potential of expert guidance throughout the virtual reality (VR) experience. Through advanced machine learning (ML) models, FundamentalVR calculates users’ risk levels of harming patients in real time, allowing for immediate intervention and correction within a training experience. This proactive approach ensures safer training environments, ultimately leading to better training results.

With the ability to rapidly evolve designs and leverage data with each iteration, FundamentalVR is driving innovation in both training simulations and product designs. This approach results in continuously improved training experiences and better products, furthering the advancement of surgical proficiency and patient outcomes.

“Our AI Tutor empowers learners by providing intuitive mentoring, driven by an expert knowledge base, providing navigation and interaction cues within the simulation,” said Vicky Smalley, Chief Technology Officer at FundamentalVR. “By focusing on learner autonomy and personalized, adaptive learning support, we are able to cultivate user engagement while fostering a culture of continuous improvement.”

FundamentalVR remains committed to advancing surgical training and elevating performance standards globally. Selected as a partner by or accredited by leading institutions such as the American Academy of Ophthalmology, American Academy of Orthopaedic Surgeons, and the Royal College of Surgeons of England, FundamentalVR continues to lead the industry in digital surgery training.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”